title: Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events?
authors.affiliation: National Heart Centre Singapore, Singapore.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Foin
authors.forename: Ryo
authors.initials: R
authors.lastname: Torii
authors.forename: Alessio
authors.initials: A
authors.lastname: Mattesini
authors.forename: Philip
authors.initials: P
authors.lastname: Wong
authors.forename: Carlo
authors.initials: C
authors.lastname: Di Mario
mesh_terms: D020341:Absorbable Implants; D054058:Acute Coronary Syndrome / Q000601:surgery*; D000787:Angina Pectoris / Q000601:surgery*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000601:surgery*; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000601:surgery*; D054457:Tissue Scaffolds
chemical_list: D000970:Antineoplastic Agents; D000068338:Everolimus